High Court Won't Revive Enzo Suit Over 'Lax' Enablement Test

The U.S. Supreme Court on Monday refused to take up Enzo Life Sciences' appeal of the Federal Circuit's "lax" standard for invalidating DNA testing patents that it asserted against Abbott Laboratories...

Already a subscriber? Click here to view full article